Novacyt Aktie - ALNOV

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Current Price

0,603

Gebot

0,592

Fragen

0,605

Volumen

0,00

0,00 Tagesbereich 0,00

0,4932 52-Wochen-Bereich 1,59

Marktkapitalisierung

42,588M

Handelsende

0,603

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

479.086

Ausgegebene Aktien

70.626.248

Dividendenrendite

Kurs-Gewinn-Verhältnis

0,00

Gewinn pro Aktie (EPS)

Erlöse

11,58M

Nettogewinn

-28,29M

Sektor

In Vitro,in Vivo Diagnostics

Branche

In Vitro,in Vivo Diagnostics

Website

www.novacyt.com

Hauptsitz

Velizy-villacoublay, Yvelines, Fra

Gegründet

Novacyt is listed in the In Vitro,in Vivo Diagnostics sector of the Euronext with ticker ALNOV. The last closing price for Novacyt was 0,60 €. Over the last year, Novacyt shares have traded in a share price range of 0,4932 € to 1,59 €.

Novacyt currently has 70.626.248 shares in issue. The market capitalisation of Novacyt is 42,59 € million.

Novacyt S.A. ("Novacyt", the "Company" or the "Group") : Mise à jour du litige avec le DHSC - date du procès indiquée

Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), spécialiste international du diagnostic clinique, annonce que la Haute Cour a...

Novacyt S.A. ("Novacyt", the "Company" or the "Group") Rapport d’activité pour l'année 2022

Le chiffre d'affaires et l'EBITDA sont conformes aux prévisions. Concentration sur la stratégie de croissance post-COVID-19 pour devenir un...

Novacyt S.A. ("Novacyt", the "Company" or the "Group"): Non-Executive Director Change

Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that Edwin Snape...

Novacyt S.A. ("Novacyt", the "Company" or the "Group"): Approval of genesig® COVID-19 3G PCR Test in the UK Under CTDA Legislation

Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company’s...

Novacyt S.A. ("Novacyt", the "Company" or the "Group"): Directorate Change

Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that David Allmond...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0.015	2.55102040816	0.588	0.614	0.588	174737	0.59977481	DE
4	-0.05	-7.65696784074	0.653	0.672	0.58	297898	0.61920633	DE
12	0.045	8.06451612903	0.558	0.84	0.542	479086	0.66133684	DE
26	-0.597	-49.75	1.2	1.59	0.542	751415	0.92914019	DE
52	0.043	7.67857142857	0.56	1.59	0.4932	549445	0.87883216	DE
156	-1.759	-74.4707874682	2.362	2.979	0.42	460514	1.09318023	DE
260	-1.697	-73.7826086957	2.3	13.96	0.42	1449527	3.67964494	DE

ALNOV - Frequently Asked Questions (FAQ)

What is the current Novacyt share price?

The current share price of Novacyt is 0,603 €

How many Novacyt shares are in issue?

Novacyt has 70.626.248 shares in issue

What is the market cap of Novacyt?

The market capitalisation of Novacyt is EUR 42,59M

What is the 1 year trading range for Novacyt share price?

Novacyt has traded in the range of 0,4932 € to 1,59 € during the past year

What is the reporting currency for Novacyt?

Novacyt reports financial results in GBP

What is the latest annual turnover for Novacyt?

The latest annual turnover of Novacyt is GBP 11,58M

What is the latest annual profit for Novacyt?

The latest annual profit of Novacyt is GBP -28,29M

What is the registered address of Novacyt?

The registered address for Novacyt is 13 AVENUE MORANE SAULNIER, VELIZY-VILLACOUBLAY, YVELINES, 78140

What is the Novacyt website address?

The website address for Novacyt is www.novacyt.com

Which industry sector does Novacyt operate in?

Novacyt operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
ABCAABC Arbitrage	5,26 € (0,00%)	0
ABAb Science	1,51 € (0,00%)	0
AALBAalberts NV	36,28 € (0,00%)	0
AAAAlan Allman Associates	4,64 € (0,00%)	0
74SW74Software SA	27,60 € (0,00%)	0
ABCAABC Arbitrage	5,26 € (0,00%)	0
ABAb Science	1,51 € (0,00%)	0
AALBAalberts NV	36,28 € (0,00%)	0
AAAAlan Allman Associates	4,64 € (0,00%)	0
74SW74Software SA	27,60 € (0,00%)	0
ABCAABC Arbitrage	5,26 € (0,00%)	0
ABAb Science	1,51 € (0,00%)	0
AALBAalberts NV	36,28 € (0,00%)	0
AAAAlan Allman Associates	4,64 € (0,00%)	0
74SW74Software SA	27,60 € (0,00%)	0

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Novacyt (ALNOV)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Über Novacyt

ALNOV Neueste Nachrichten

Novacyt S.A. ("Novacyt", the "Company" or the "Group") : Mise à jour du litige avec le DHSC - date du procès indiquée

Novacyt S.A. ("Novacyt", the "Company" or the "Group") Rapport d’activité pour l'année 2022

Novacyt S.A. ("Novacyt", the "Company" or the "Group"): Non-Executive Director Change

Novacyt S.A. ("Novacyt", the "Company" or the "Group"): Approval of genesig® COVID-19 3G PCR Test in the UK Under CTDA Legislation

Novacyt S.A. ("Novacyt", the "Company" or the "Group"): Directorate Change

ALNOV - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Novacyt (ALNOV) Börsenkurse

Novacyt (ALNOV)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Über Novacyt

ALNOV Neueste Nachrichten

Novacyt S.A. ("Novacyt", the "Company" or the "Group") : Mise à jour du litige avec le DHSC - date du procès indiquée

Novacyt S.A. ("Novacyt", the "Company" or the "Group") Rapport d’activité pour l'année 2022

Novacyt S.A. ("Novacyt", the "Company" or the "Group"): Non-Executive Director Change

Novacyt S.A. ("Novacyt", the "Company" or the "Group"): Approval of genesig® COVID-19 3G PCR Test in the UK Under CTDA Legislation

Novacyt S.A. ("Novacyt", the "Company" or the "Group"): Directorate Change

ALNOV - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen